These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 30628634

  • 1. Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis.
    Tribó MJ, Turroja M, Castaño-Vinyals G, Bulbena A, Ros E, García-Martínez P, Tausk F, Sagristà M, Pujol RM, Ferran M, Gallardo F.
    Acta Derm Venereol; 2019 Apr 01; 99(4):417-422. PubMed ID: 30628634
    [Abstract] [Full Text] [Related]

  • 2. Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns - a cross-sectional study.
    da Silva N, Augustin M, Hilbring C, Braren-von Stülpnagel CC, Sommer R.
    BMJ Open; 2022 Sep 23; 12(9):e055477. PubMed ID: 36153012
    [Abstract] [Full Text] [Related]

  • 3. Determinants of Psychosocial Health in Psoriatic Patients: A Multi-national Study.
    Lesner K, Reich A, Szepietowski JC, Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GB, Misery L, Szabó C, Linder D, Sampogna F, Evers AWM, Halvorsen JA, Balieva F, Lvov A, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J.
    Acta Derm Venereol; 2017 Nov 15; 97(10):1182-1188. PubMed ID: 28795763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reversibility of alexithymia with effective treatment of moderate-to-severe psoriasis: longitudinal data from EPIDEPSO.
    Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke MA, Kirby B, Brunori M, Bergmans P, Smirnov P, Rundle J, Castiglia A, Lavie F, Paul C.
    Br J Dermatol; 2019 Feb 15; 180(2):397-403. PubMed ID: 30269346
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients.
    Kotrulja L, Tadinac M, Joki-Begi NA, Gregurek R.
    Acta Derm Venereol; 2010 May 15; 90(3):251-6. PubMed ID: 20526541
    [Abstract] [Full Text] [Related]

  • 8. Associations of the quality of life and psychoemotional state with sociodemographic factors in patients with psoriasis.
    Petraškienė R, Valiukevičienė S, Macijauskienė J.
    Medicina (Kaunas); 2016 May 15; 52(4):238-243. PubMed ID: 27530772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Chinese cross-sectional study on depression and anxiety symptoms in patients with psoriasis vulgaris.
    Tian Z, Huang Y, Yue T, Zhou J, Tao L, Han L, Yan K, Huang Q, Zhang Z, Shao C.
    Psychol Health Med; 2019 Mar 15; 24(3):269-280. PubMed ID: 30293440
    [Abstract] [Full Text] [Related]

  • 14. Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis.
    Innamorati M, Quinto RM, Imperatori C, Lora V, Graceffa D, Fabbricatore M, Lester D, Contardi A, Bonifati C.
    Compr Psychiatry; 2016 Oct 15; 70():200-8. PubMed ID: 27565774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated prevalence of Type D (distressed) personality in moderate to severe psoriasis is associated with mood status and quality of life impairment: a comparative pilot study.
    Molina-Leyva A, Caparros-delMoral I, Ruiz-Carrascosa JC, Naranjo-Sintes R, Jimenez-Moleon JJ.
    J Eur Acad Dermatol Venereol; 2015 Sep 15; 29(9):1710-7. PubMed ID: 25623927
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quality of life and psychosocial aspects in Greek patients with psoriasis: a cross-sectional study.
    Kouris A, Christodoulou C, Stefanaki C, Livaditis M, Tsatovidou R, Kouskoukis C, Petridis A, Kontochristopoulos G.
    An Bras Dermatol; 2015 Sep 15; 90(6):841-5. PubMed ID: 26734865
    [Abstract] [Full Text] [Related]

  • 19. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls.
    Karelson M, Silm H, Kingo K.
    Acta Derm Venereol; 2013 Jul 06; 93(4):446-50. PubMed ID: 23306792
    [Abstract] [Full Text] [Related]

  • 20. Symptom dimensions of depression and anxiety and the metabolic syndrome.
    Luppino FS, van Reedt Dortland AK, Wardenaar KJ, Bouvy PF, Giltay EJ, Zitman FG, Penninx BW.
    Psychosom Med; 2011 Apr 06; 73(3):257-64. PubMed ID: 21257975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.